|Day's Range||0.12 - 0.14|
|52 Week Range||0.07 - 0.71|
|PE Ratio (TTM)||-0.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The San Diego-based company said it had a loss of 2 cents per share. The biopharmaceutical company posted revenue of $83,000 in the period. For the year, the company reported that its loss widened to $36.1 ...
Mast Therapeutics will merge with privately-held Savara Inc, which will be the surviving entity.
Mast Therapeutics reported a third-quarter loss of 8.2 million, compared to $9.9 million last year.